Hugh Taggart

Reduction of lecithin-cholesterol acyltransferase, apolipoprotein D and the Lp(a) lipoprotein with the anabolic steroid stanozolol

John J. Albers, Hugh Taggart, Deborah Applebaum‐Bowden et al. · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · 1984 · 188 citations

Life Sciences, Biochemistry, Pharmacology +16

Reduction in high density lipoproteins by anabolic steroid (stanozolol) therapy for postmenopausal osteoporosis

Hugh Taggart, Deborah Applebaum‐Bowden, Steven M. Haffner et al. · Metabolism · 1982 · 120 citations

Medicine, Endocrinology, Pharmacotherapy +16

Upper Gastrointestinal Tract Safety of Risedronate: A Pooled Analysis of 9 Clinical Trials

Hugh Taggart, Michael A. Bolognese, Robert Lindsay et al. · Mayo Clinic Proceedings · 2002 · 104 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +5

Bone mineral density in relation to medical and lifestyle risk factors for osteoporosis in premenopausal, menopausal and postmenopausal women in general practice.

A McKnight, Keith Steele, Karen Mills et al. · PubMed · 1995 · 26 citations

Medicine, Preventive Medicine, Bone Metabolism +16

A study of male patients with forearm fracture in Northern Ireland

Stephen Wright, T. R. O. Beringer, Hugh Taggart et al. · Clinical Rheumatology · 2006 · 21 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +11